| 000 | 00913 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516174748.0 | ||
| 264 | 0 | _c20131223 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1532-6535 | ||
| 024 | 7 |
_a10.1038/clpt.2013.120 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRobertson, D G | |
| 245 | 0 | 0 |
_aMetabolomics in drug discovery and development. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cNov 2013 |
||
| 300 |
_a559-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetabolomics _xmethods |
| 700 | 1 | _aFrevert, U | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 94 _gno. 5 _gp. 559-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.2013.120 _zAvailable from publisher's website |
| 999 |
_c23189738 _d23189738 |
||